Zentalis Pharmaceuticals’s (ZNTL) Moving Averages Convergence Divergence (MACD) indicator is -0.24, suggesting Zentalis Pharmaceuticals is a Sell.
Zentalis Pharmaceuticals’s (ZNTL) 20-Day exponential moving average is 1.97, while Zentalis Pharmaceuticals’s (ZNTL) share price is $1.70, making it a Sell.
Zentalis Pharmaceuticals’s (ZNTL) 50-Day exponential moving average is 2.48, while Zentalis Pharmaceuticals’s (ZNTL) share price is $1.70, making it a Sell.
Zentalis Pharmaceuticals’s (ZNTL) 10-Day exponential moving average is 1.80, while Zentalis Pharmaceuticals’s (ZNTL) share price is $1.70, making it a Sell.
Zentalis Pharmaceuticals’s (ZNTL) 100-Day exponential moving average is 2.94, while Zentalis Pharmaceuticals’s (ZNTL) share price is $1.70, making it a Sell.
Zentalis Pharmaceuticals’s (ZNTL) stock price is $1.70 and Zentalis Pharmaceuticals’s (ZNTL) 50-day simple moving average is 2.53, creating a Sell signal.
Zentalis Pharmaceuticals’s (ZNTL) stock price is $1.70 and Zentalis Pharmaceuticals’s (ZNTL) 100-day simple moving average is 3.45, creating a Sell signal.
Zentalis Pharmaceuticals’s (ZNTL) stock price is $1.70 and Zentalis Pharmaceuticals’s (ZNTL) 200-day simple moving average is 3.40, creating a Sell signal.